Muhamad Sajjad Sadiq et al. 2024. Effectiveness of SGLT2 inhibitor (Empagliflozin) in reduction of albuminuria in type 2 Diabetics. Pioneer Journal of Biostatistics and Medical Research. 1, 4 (May 2024), 26–38. DOI:https://doi.org/10.61171/2av4gt96.